Clinical Trial Update: ST250 as a Therapeutic Option for Head & Neck Reconstruction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ST250 for head and neck reconstruction in tonsillitis patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tonsillitis

Drugs mentioned

• ST250

Snippet

Sponsor: Alaa Emara | Conditions: Tonsillitis | Phase 1, Phase 2 | Status: RECRUITING